JNJ vs REGN
By Alex · Tickerpine
Johnson & Johnson vs Regeneron Pharmaceuticals, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | REGN |
|---|---|---|
| Price | $254.66 | $632.90 |
| Market cap | $613.02B | $66.35B |
| P/E ratio | 29.5 | 15.5 |
| ROE | 26.42% | 14.55% |
| Profit margin | 21.83% | 29.65% |
| Revenue growth | 9.90% | 19.00% |
| Dividend yield | 2.10% | 0.59% |
| Beta | 0.26 | 0.24 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs REGN in plain English
- JNJ is the bigger company — about 9.2× the market cap of REGN.
- REGN is cheaper on earnings (P/E 15.5 vs 29.5).
- JNJ earns a higher return on equity (26% vs 15%).
- REGN is growing revenue faster (19% vs 10%).
- JNJ has the higher dividend yield (2.10% vs 0.59%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
REGN return calculator
See what $1,000 in Regeneron Pharmaceuticals, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.